Influence of tumour condition on the macrophage activity in Candida albicans infection

J Venturini1, M R de Camargo, M C Félix

  • 1Experimental Immunopathology Laboratory, Department of Biological Sciences, College of Sciences, Sao Paulo State University-UNESP, Bauru, São Paulo, Brazil.

Insights

Tumor progression in mice weakens macrophage response to Candida albicans. Early tumor growth enhances immune activity, but later stages increase susceptibility to opportunistic fungal infections.

Area of Science:

  • Immunology
  • Mycology
  • Cancer Biology

Background:

  • Opportunistic fungal infections pose risks to immunocompromised individuals, including cancer patients.
  • Macrophages play a crucial role in host defense against microbial pathogens.

Purpose of the Study:

  • To investigate the impact of tumor progression on macrophage function and host defense against Candida albicans.
  • To analyze the production of key immune mediators like hydrogen peroxide (H2O2) and TNF-alpha by macrophages in tumor-bearing mice.

Main Methods:

  • Peritoneal macrophages from Ehrlich tumor-bearing mice (TBM) at different stages of tumor growth (days 7, 14, 21) were infected with Candida albicans.
  • Production of H2O2, nitric oxide, and TNF-alpha by macrophages was measured.
  • Fungal clearance and dissemination were assessed.

Main Results:

  • At early tumor stages (day 7), TBM showed increased H2O2 and TNF-alpha production, leading to enhanced fungal clearance.
  • As tumors progressed (days 14, 21), macrophage production of H2O2 and TNF-alpha significantly declined.
  • This decline in immune response correlated with increased Candida albicans dissemination.

Conclusions:

  • Macrophage-mediated defense against Candida albicans is effective only during the initial phases of tumor development.
  • Advanced tumor growth impairs macrophage function, compromising the host's ability to control opportunistic fungal infections.
  • Understanding these dynamics is crucial for developing therapeutic strategies against fungal infections in cancer patients.